23 May 2013
Keywords: indevus, submits, nda, nebido, fda, usa, pharmaceuticals
Article | 12 November 2007
The USA's Indevus Pharmaceuticals says that the Food and Drug Administration has accepted for review its New Drug Application for
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 November 2007
19 November 2007
22 May 2013
© 2013 thepharmaletter.com